| |
Latest 10 SEC filings (by transaction date) for APLS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 15/24 | Apr 12/24 | Dunlop A. Sinclair | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -1,500 | |
Apr 15/24 | Apr 12/24 | Dunlop A. Sinclair | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,500 | $13.19 |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -69,107 | |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Common Stock | S - Open market or private sale | -4,728 | $54.92 |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Common Stock | S - Open market or private sale | -64,379 | $54.12 |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 69,107 | $3.76 |
Apr 2/24 | Apr 1/24 | Sullivan Timothy Eugene | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -4,000 | |
Apr 2/24 | Apr 1/24 | Sullivan Timothy Eugene | Direct Ownership | Common Stock | S - Open market or private sale | -4,000 | $58.66 |
Apr 2/24 | Apr 1/24 | Sullivan Timothy Eugene | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,000 | $10.03 |
Mar 20/24 | Mar 19/24 | Dunlop A. Sinclair | Indirect Ownership | Common Stock | S - Open market or private sale | -18,681 | $57.18 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for APLS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 15/24 | Apr 12/24 | Dunlop A. Sinclair | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -1,500 | |
Apr 15/24 | Apr 12/24 | Dunlop A. Sinclair | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,500 | $13.19 |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -69,107 | |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Common Stock | S - Open market or private sale | -4,728 | $54.92 |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Common Stock | S - Open market or private sale | -64,379 | $54.12 |
Apr 9/24 | Apr 8/24 | Deschatelets Pascal | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 69,107 | $3.76 |
Apr 2/24 | Apr 1/24 | Sullivan Timothy Eugene | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -4,000 | |
Apr 2/24 | Apr 1/24 | Sullivan Timothy Eugene | Direct Ownership | Common Stock | S - Open market or private sale | -4,000 | $58.66 |
Apr 2/24 | Apr 1/24 | Sullivan Timothy Eugene | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,000 | $10.03 |
Mar 20/24 | Mar 19/24 | Dunlop A. Sinclair | Indirect Ownership | Common Stock | S - Open market or private sale | -18,681 | $57.18 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Biomarin Pharmaceutical (OQ:BMRN) |
ADMA Biologics (OQ:ADMA) |